A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
Completed
- Conditions
- Asthma
- Registration Number
- NCT00986219
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 696
Inclusion Criteria
- Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time
Exclusion Criteria
- Patient with a cardiac disease (congestive heart failure, coronary heart disease)
- Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma Day 1
- Secondary Outcome Measures
Name Time Method The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities. Day 1 The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ). Day 1 The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms. Day 1
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie asthma symptom expression in NCT00986219?
How does AstraZeneca's observational study compare to standard-of-care asthma assessments?
What biomarkers correlate with asthma symptom severity in primary care settings?
Are there adverse events associated with asthma communication strategies in clinical practice?
What alternative therapies show efficacy in asthma management alongside communication studies?
Trial Locations
- Locations (1)
Research Site
🇬🇷Lakonia, Greece
Research Site🇬🇷Lakonia, Greece